v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Ordinary Shares
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Treasury Shares
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   55,349,000        
Beginning balance at Dec. 31, 2024 $ 92,166 $ 10 $ 439,357 $ (1,666) $ (180) $ (345,355)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of ordinary shares under the Stock Incentive Plan (in shares)   3,000        
Issuance of ordinary shares under the Stock Incentive Plan 2   2      
Share-based compensation expense 942   942      
Net loss (10,272)         (10,272)
Net unrealized losses on available-for-sale investments (1)     (1)    
Foreign currency translation adjustments 62     62    
Ending balance (in shares) at Mar. 31, 2025   55,352,000        
Ending balance at Mar. 31, 2025 82,899 $ 10 440,301 (1,605) (180) (355,627)
Beginning balance (in shares) at Dec. 31, 2024   55,349,000        
Beginning balance at Dec. 31, 2024 92,166 $ 10 439,357 (1,666) (180) (345,355)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (23,171)          
Net unrealized losses on available-for-sale investments (7)          
Ending balance (in shares) at Jun. 30, 2025   55,580,000        
Ending balance at Jun. 30, 2025 71,342 $ 10 441,413 (1,375) (180) (368,526)
Beginning balance (in shares) at Mar. 31, 2025   55,352,000        
Beginning balance at Mar. 31, 2025 82,899 $ 10 440,301 (1,605) (180) (355,627)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of ordinary shares under the Employee Stock Purchase Plan (in shares)   204,000        
Issuance of ordinary shares under the Employee Stock Purchase Plan 143   143      
Issuance of ordinary shares under the Stock Incentive Plan (in shares)   24,000        
Issuance of ordinary shares under the Stock Incentive Plan 18   18      
Share-based compensation expense 951   951      
Net loss (12,899)         (12,899)
Net unrealized losses on available-for-sale investments (6)     (6)    
Foreign currency translation adjustments 236     236    
Ending balance (in shares) at Jun. 30, 2025   55,580,000        
Ending balance at Jun. 30, 2025 $ 71,342 $ 10 441,413 (1,375) (180) (368,526)
Beginning balance (in shares) at Dec. 31, 2025 56,442,308 56,442,000        
Beginning balance at Dec. 31, 2025 $ 41,980 $ 10 444,176 (1,191) (180) (400,835)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of ordinary shares in a private placement, net of issuance costs (in shares)   6,130,000        
Issuance of ordinary shares in a private placement, net of issuance costs 18,577 $ 1 18,576      
Issuance of ordinary shares under the Stock Incentive Plan (in shares)   140,000        
Issuance of ordinary shares under the Stock Incentive Plan 137   137      
Share-based compensation expense 1,199   1,199      
Net loss (19,398)         (19,398)
Net unrealized losses on available-for-sale investments (4)     (4)    
Foreign currency translation adjustments 132     132    
Ending balance (in shares) at Mar. 31, 2026   62,712,000        
Ending balance at Mar. 31, 2026 $ 42,623 $ 11 464,088 (1,063) (180) (420,233)
Beginning balance (in shares) at Dec. 31, 2025 56,442,308 56,442,000        
Beginning balance at Dec. 31, 2025 $ 41,980 $ 10 444,176 (1,191) (180) (400,835)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (36,682)          
Net unrealized losses on available-for-sale investments $ (5)          
Ending balance (in shares) at Jun. 30, 2026 62,974,309 62,974,000        
Ending balance at Jun. 30, 2026 $ 26,861 $ 11 465,509 (962) (180) (437,517)
Beginning balance (in shares) at Mar. 31, 2026   62,712,000        
Beginning balance at Mar. 31, 2026 42,623 $ 11 464,088 (1,063) (180) (420,233)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of ordinary shares in a private placement, net of issuance costs (16)   (16)      
Issuance of ordinary shares under the Employee Stock Purchase Plan (in shares)   252,000        
Issuance of ordinary shares under the Employee Stock Purchase Plan 176   176      
Issuance of ordinary shares under the Stock Incentive Plan (in shares)   10,000        
Share-based compensation expense 1,261   1,261      
Net loss (17,284)         (17,284)
Net unrealized losses on available-for-sale investments (1)     (1)    
Foreign currency translation adjustments $ 102     102    
Ending balance (in shares) at Jun. 30, 2026 62,974,309 62,974,000        
Ending balance at Jun. 30, 2026 $ 26,861 $ 11 $ 465,509 $ (962) $ (180) $ (437,517)